-
November 13: The Week in Cancer News
A survey indicates that the pandemic is reducing cancer patients' willingness to enroll in cancer clinical trials, and a study find that indoor tanning increases risk of developing melanoma multiple times.
by Kate Yandell
-
November 6: The Week in Cancer News
Cancer survivors who use the internet for health-related reasons are more likely to be dissatisfied with their care, and liquid biopsy could misidentify which prostate cancer patients could benefit from targeted therapy.
by Kate Yandell
-
October 30: The Week in Cancer News
The U.S. Preventive Services Task Force releases draft guidance suggesting lowering the age at which people should begin routine colorectal cancer screening, and an ovarian cancer patient considers what clinical trials owe participants.
by Kate Yandell
-
October 23: The Week in Cancer News
A newly discovered set of salivary glands could have implications for protecting head and neck cancer patients from radiation side effects, and younger melanoma patients respond better to a targeted therapy than older patients.
by Kate Yandell
-
October 16: The Week in Cancer News
A study finds that some commercially insured patients getting screening colonoscopies receive a bill for out-of-network services, and a machine learning algorithm helps nudge oncology clinicians to talk about prognosis and the end of life.
by Kate Yandell
-
October 9: The Week in Cancer News
A study finds that more than half of cancer patients participate in clinical trials when asked, and an annual survey sheds light on cancer patients' experience of the coronavirus pandemic.
by Kate Yandell
-
October 2: The Week in Cancer News
A study finds that human papillomavirus vaccination reduces the rate of cervical cancer, and pediatric cancer researchers identify tradeoffs between reducing recurrence risk and minimizing long-term effects of treatment.
by Kate Yandell
-
September 25: The Week in Cancer News
A trial shows that a form of targeted chemotherapy lengthens life for people with metastatic, triple-negative breast cancer, and researchers release more data on targeting KRAS-mutated lung cancer.
by Kate Yandell
-
Cancer Diagnoses and Research Continue
Amid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
by Kevin McLaughlin
-
September 18: The Week in Cancer News
A report finds that more progress is needed to reduce cancer health disparities, and a study indicates that drinking large amounts of coffee may slightly lengthen survival for people with advanced or metastatic colorectal cancer.
by Kate Yandell
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona